Wim Vermeulen Selected Research

Cockayne Syndrome (Syndrome, Cockayne)

12/2021	Retraction Notice to: Cockayne Syndrome A and B Proteins Differentially Regulate Recruitment of Chromatin Remodeling and Repair Factors to Stalled RNA Polymerase II In Vivo.
12/2018	TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A.
10/2018	Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
1/2018	The transcription-coupled DNA repair-initiating protein CSB promotes XRCC1 recruitment to oxidative DNA damage.
1/2016	A ubiquitylation site in Cockayne syndrome B required for repair of oxidative DNA damage, but not for transcription-coupled nucleotide excision repair.
6/2010	A ubiquitin-binding domain in Cockayne syndrome B required for transcription-coupled nucleotide excision repair.
8/2006	An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.
1/2006	RETRACTED: Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo.
12/2004	Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.
7/2004	DNA damage stabilizes interaction of CSB with the transcription elongation machinery.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wim Vermeulen Research Topics

Disease

11	Cockayne Syndrome (Syndrome, Cockayne) 12/2021 - 09/2002
6	Neoplasms (Cancer) 01/2021 - 08/2006
5	Xeroderma Pigmentosum (Kaposi's Disease) 10/2013 - 07/2003
4	Genomic Instability 07/2021 - 11/2007
4	Trichothiodystrophy Syndromes 01/2021 - 07/2004
3	Hypersensitivity (Allergy) 01/2019 - 03/2007
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017 - 05/2006
2	Human Influenza (Influenza) 10/2021 - 01/2021
2	Fever (Fevers) 01/2021 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 09/2006
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 09/2006
2	Fragile X Tremor Ataxia Syndrome 01/2019 - 09/2006
2	Colitis 09/2014 - 01/2013
2	Inflammation (Inflammations) 04/2013 - 10/2012
1	Complementation Group G Xeroderma Pigmentosum 03/2022
1	Neurodevelopmental Disorders 01/2021
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Microcephaly 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Huntington Disease (Huntington's Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Fanconi Anemia (Fanconi's Anemia) 10/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2014
1	Leukemia 10/2013
1	Necrosis 10/2012
1	UV-Sensitive Syndrome 05/2012
1	Portal Hypertension 03/2010
1	Fibrosis (Cirrhosis) 03/2010
1	Fatty Liver 03/2010
1	Melanoma (Melanoma, Malignant) 10/2009
1	Progeria (Hutchinson Gilford Syndrome) 08/2006
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 07/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2002
1	Persistent Infection 04/2002

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2002
4	UbiquitinIBA 01/2021 - 09/2006
3	RNA Polymerase II (RNA Polymerase B)IBA 12/2021 - 07/2004
3	Peroxidase (Myeloperoxidase)IBA 04/2013 - 10/2012
2	VaccinesIBA 10/2021 - 01/2021
2	Peptide Elongation Factors (Elongation Factor)IBA 07/2021 - 01/2021
2	Transcription Factor TFIIHIBA 01/2019 - 07/2004
2	PlatinumIBA 10/2018 - 10/2018
2	Pharmaceutical PreparationsIBA 10/2018 - 10/2018
2	Phosphotransferases (Kinase)IBA 01/2017 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 01/2011
2	Sulfonic AcidsIBA 09/2014 - 01/2013
2	NucleotidesIBA 10/2013 - 08/2006
2	ATP dependent 26S protease (26S proteasome)IBA 10/2013 - 09/2006
2	Peptides (Polypeptides)IBA 10/2009 - 06/2006
1	EndonucleasesIBA 03/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2021
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 10/2021
1	SulfurIBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	cysteinyl-tRNA synthetaseIBA 01/2019
1	poly(glycyl-alanyl)IBA 01/2019
1	Staphylococcal Protein A (Protein A)IBA 12/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018
1	Discoidin Domain ReceptorsIBA 10/2018
1	IgA receptor (protein B)IBA 01/2018
1	transcription factor TFIIE (TFIIE)IBA 12/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	MutagensIBA 01/2017
1	CorticosteroneIBA 09/2014
1	Lysine (L-Lysine)FDA Link 10/2013
1	sym-trinitrobenzeneIBA 01/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	InterferonsIBA 10/2012
1	InterleukinsIBA 10/2012
1	Vasoconstrictor AgentsIBA 03/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2009
1	MART-1 AntigenIBA 10/2009
1	EnzymesIBA 09/2009
1	Biological ProductsIBA 12/2008
1	TrabectedinIBA 12/2008
1	ChromatinIBA 11/2007
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2007
1	A-Form DNA (A-DNA)IBA 09/2002
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 09/2002
1	Viral ProteinsIBA 04/2002

Therapy/Procedure

1	Therapeutics 01/2019
1	Enema (Enemas) 01/2013